Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-24 @ 8:26 AM
Study NCT ID:
NCT00124059
Status:
COMPLETED
Last Update Posted:
2015-10-06
First Post:
2005-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.
Sponsor:
University of Pennsylvania
Organization:
Study Overview
Official Title:
A Double-Blind Study of Quetiapine Fumarate (Seroquel) for the Treatment of Type A vs.Type B Alcoholics.
Status:
COMPLETED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether seroquel is effective in the treatment of type A and type B alcohol dependence.
Detailed Description:
The purpose of this study is to obtain preliminary data regarding the safety, efficacy and tolerability of quetiapine \[Seroquel (SQL)\] in treating Type A vs B alcohol dependent outpatients seeking treatment.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: